Skip to main content
. 2022 Jul 13;158(8):871–878. doi: 10.1001/jamadermatol.2022.2721

Figure 2. Molluscum Contagiosum Lesion Clearance Through Week 12.

Figure 2.

A, Percentage of patients in the ITT population who achieved complete clearance of molluscum contagiosum lesions (defined as having a lesion count of 0) through week 12. B, Percentage of patients in the ITT population with 0 or 1 lesion(s) at week 12. C, Percentage of patients in the ITT population with ≥90% clearance at week 12. P values are based on logistic regression analysis of the treatment differences (berdazimer gel to vehicle) adjusted for the following factors: investigator type (dermatologist vs other), number of patients per household (1 vs 2), baseline BOTE inflammation score (0 vs ≥1), age in years (6 months to <3, 3 to <4, 4 to <5, 5 to <6, 6 to <7, 7 to <8, 8 to <9, 9 to <12, and ≥12), and baseline lesion count. BOTE denotes beginning-of-the-end and ITT, intention-to-treat.